Accendra Health (ACH) CFO surrenders 11,286 shares for tax withholding

Rhea-AI Filing Summary

ACCENDRA HEALTH INC/VA/ executive reports routine tax withholding share disposition. EVP & CFO Jonathan A. Leon surrendered 11,286 shares of common stock on 2026-03-20 to the company to cover tax withholding tied to vesting of restricted stock. This was not an open-market sale. After the transaction, he directly holds 292,303 shares of common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Leon Jonathan A

(Last) (First) (Middle)

ACCENDRA HEALTH, INC.

4435 WATERFRONT DRIVE

(Street)

GLEN ALLEN VIRGINIA 23060

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACCENDRA HEALTH INC/VA/ [ ACH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/20/2026		F		11,286(1)	D	$2.03	292,303	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

	Jonathan A. Leon, by Rosemarie W. France POA	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ACCENDRA HEALTH (ACH) report in this Form 4?

ACCENDRA HEALTH reported that EVP & CFO Jonathan A. Leon surrendered 11,286 shares of common stock to the company. The shares covered tax withholding obligations related to vesting of restricted stock, rather than an open-market sale or discretionary trading activity.

Was the ACCENDRA HEALTH (ACH) Form 4 transaction an open-market sale?

No, the Form 4 shows no open-market sale. The 11,286 shares of ACCENDRA HEALTH common stock were surrendered to the issuer solely to satisfy tax withholding obligations arising from vesting of restricted stock granted to EVP & CFO Jonathan A. Leon.

How many ACCENDRA HEALTH (ACH) shares does the CFO hold after this Form 4?

Following the tax-withholding disposition, EVP & CFO Jonathan A. Leon directly holds 292,303 shares of ACCENDRA HEALTH common stock. This remaining position illustrates that the reported share surrender represents a small, routine adjustment rather than a major change in his ownership stake.

What does transaction code "F" mean in the ACCENDRA HEALTH (ACH) Form 4?

Transaction code "F" in the ACCENDRA HEALTH Form 4 indicates a tax-withholding disposition. Shares are delivered back to the issuer to pay exercise price or tax liabilities, here covering withholding taxes from vesting restricted stock, not reflecting an open-market buy or sell decision.

What role does the reporting person hold at ACCENDRA HEALTH (ACH)?

The reporting person on this Form 4, Jonathan A. Leon, serves as Executive Vice President and Chief Financial Officer of ACCENDRA HEALTH. The reported transaction reflects equity compensation administration and related tax withholding, typical for senior executives receiving restricted stock awards.